공시 • May 07
Danaher Corporation announces Quarterly dividend, payable on July 31, 2026 Danaher Corporation announced Quarterly dividend of USD 0.4000 per share payable on July 31, 2026, ex-date on June 26, 2026 and record date on June 26, 2026. 공시 • Mar 26
Danaher Corporation, Annual General Meeting, May 05, 2026 Danaher Corporation, Annual General Meeting, May 05, 2026. 공시 • Mar 21
Danaher Corporation to Report Q1, 2026 Results on Apr 21, 2026 Danaher Corporation announced that they will report Q1, 2026 results at 6:00 AM, US Eastern Standard Time on Apr 21, 2026 공시 • Feb 25
Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026 Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026. 공시 • Feb 11
Danaher Corporation Announces Retirement of Director, Jessica L. Mega, Effective February 5, 2026 Danaher Corporation announced that Jessica L. Mega notified the Board of Directors of her retirement from the Board as of February 5, 2026, due to commitments related to her other professional obligations. Dr. Mega's decision was not the result of any disagreement with Danaher on any matter relating to Danaher's operations, policies or practices. 공시 • Dec 17
Danaher Corporation to Report Q4, 2025 Results on Jan 28, 2026 Danaher Corporation announced that they will report Q4, 2025 results at 6:00 AM, US Eastern Standard Time on Jan 28, 2026 공시 • Dec 10
Danaher Corporation Announces Quarterly Dividend, Payable on January 30, 2026 Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025. 공시 • Nov 08
Danaher Corporation Announces Retirement of John T. Schwieters from Its Board Danaher Corporation announced on November 6, 2025, John T. Schwieters notified the company’s Board of Directors that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting. Mr. Schwieters’ decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The size of the Board will be reduced from thirteen to twelve members as of the time of Mr. Schwieters’ retirement. 공시 • Oct 22
Danaher Corporation Provides Revenue Guidance for the Fourth Quarter of 2025 and for the Full Year 2026 Danaher Corporation provided revenue guidance for the fourth quarter of 2025 and for the full year 2026. In the fourth quarter, the company expects core revenue to grow in the low single-digit percent range as it expects market conditions to be largely consistent with what the company saw in third quarter.
For the full year 2026, the company expects core revenue growth in the 3% to 6% range as it is assuming modest recovery across end markets. 공시 • Sep 24
Danaher Corporation to Report Q3, 2025 Results on Oct 21, 2025 Danaher Corporation announced that they will report Q3, 2025 results at 6:00 AM, Eastern Standard Time on Oct 21, 2025 공시 • Sep 10
Danaher Announces Quarterly Dividend, Payable on October 31, 2025 Danaher Corporation has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025. 공시 • Aug 01
Danaher Corporation Announces Executive Changes Danaher Corporation announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan Leiken succeeds Brian Ellis, who will retire after nearly a decade of distinguished service as Danaher's General Counsel. Mr. Ellis will remain at Danaher in an executive officer role through February 2026 to support the transition. Prior to joining Danaher, Mr. Leiken served as Executive Vice President, Chief Legal Officer, and Corporate Secretary at Dollar Tree Inc., a Fortune 150 company, where he oversaw corporate governance, ethics and compliance, sustainability and regulatory affairs. Prior to that, he held the same role at Diebold Nixdorf Inc., a global technology company, where he also led intellectual property, internal audit and ESG functions. Mr. Leiken's career includes serving as a federal prosecutor in the U.S. Attorney's Office for the Southern District of New York, where he was recognized for superior performance by multiple federal agencies. He has also been a partner at a global law firm, advising Fortune 500 companies and major institutions on complex litigation, corporate strategy and regulatory matters. He holds a J.D., cum laude, from the University of Pennsylvania Law School and a B.A. in Political Science, magna cum laude, from Brandeis University. 공시 • Jul 22
Danaher Corporation Announces Chief Financial Officer Changes, Effective February 28 , 2026 Danaher Corporation announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the Company, as he begins a gradual transition to retirement, after more than 20 years with Danaher. Mr. McGrew has served as Danaher's CFO since January 2019. He joined Danaher in 2004 as Director, M&A Finance and served in roles of increasing responsibility including Vice President, Investor Relations from 2009 to 2014 and as a Danaher Group CFO from 2012 to 2018. During his tenure as CFO, Danaher meaningfully increased its growth and margin profile, and nearly doubled both its revenue and market capitalization. Mr. Gugino joined Danaher in 2013 as Director, Investor Relations and served as Vice President, Investor Relations from 2014 to 2022. He has served as Vice President of Financial Planning & Analysis since 2019 and additionally as Group Chief Financial Officer in the Company's Life Sciences Innovations Group since 2021. Prior to joining Danaher, he was a Vice President of Equity Research at Barclays and Morgan Stanley, and an Associate at KPMG. He holds a Bachelor of Science degree in Accounting and a Master of Accountancy and Professional Consultancy from Villanova University. 공시 • Jun 28
Danaher Corporation(NYSE:DHR) dropped from Russell Top 50 Index Danaher Corporation(NYSE:DHR) dropped from Russell Top 50 Index 공시 • Jun 18
Danaher Corporation to Report Q2, 2025 Results on Jul 22, 2025 Danaher Corporation announced that they will report Q2, 2025 results at 6:00 AM, US Eastern Standard Time on Jul 22, 2025 공시 • May 07
Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025 Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025. 공시 • Mar 28
Danaher Corporation, Annual General Meeting, May 06, 2025 Danaher Corporation, Annual General Meeting, May 06, 2025. 
